AU640449B2 - Condensed thiazole compounds, their production and use - Google Patents
Condensed thiazole compounds, their production and use Download PDFInfo
- Publication number
- AU640449B2 AU640449B2 AU71243/91A AU7124391A AU640449B2 AU 640449 B2 AU640449 B2 AU 640449B2 AU 71243/91 A AU71243/91 A AU 71243/91A AU 7124391 A AU7124391 A AU 7124391A AU 640449 B2 AU640449 B2 AU 640449B2
- Authority
- AU
- Australia
- Prior art keywords
- compound
- group
- salt
- compound according
- hydrogen atom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
- C07D211/76—Oxygen atoms attached in position 2 or 6
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2-44095 | 1990-02-23 | ||
| JP4409590 | 1990-02-23 | ||
| JP25965690 | 1990-09-27 | ||
| JP2-259656 | 1990-09-27 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU7124391A AU7124391A (en) | 1991-08-29 |
| AU640449B2 true AU640449B2 (en) | 1993-08-26 |
Family
ID=26383943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU71243/91A Ceased AU640449B2 (en) | 1990-02-23 | 1991-02-20 | Condensed thiazole compounds, their production and use |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5153201A (enExample) |
| EP (1) | EP0443588B1 (enExample) |
| KR (1) | KR910021406A (enExample) |
| AT (1) | ATE181553T1 (enExample) |
| AU (1) | AU640449B2 (enExample) |
| CA (1) | CA2036905C (enExample) |
| DE (1) | DE69131359T2 (enExample) |
| IE (1) | IE910570A1 (enExample) |
| IL (1) | IL97249A (enExample) |
| NZ (1) | NZ237187A (enExample) |
| TW (1) | TW206970B (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5857296A (en) * | 1995-05-17 | 1996-11-29 | Eli Lilly And Company | Use of leukotriene antagonists for alzheimer's disease |
| US5653903A (en) * | 1995-06-27 | 1997-08-05 | Ppg Industries, Inc. | L-shaped heating element with radiused end for a windshield |
| US5886321A (en) * | 1996-12-19 | 1999-03-23 | Ppg Industries, Inc. | Arrangement for heating the wiper rest area of a vehicle windshield |
| GB2418427A (en) | 2004-09-02 | 2006-03-29 | Univ Cambridge Tech | Ligands for G-protein coupled receptors |
| WO2006076569A2 (en) * | 2005-01-12 | 2006-07-20 | Bristol-Myers Squibb Company | Bicyclic heterocycles as cannabinoid receptor modulators |
| GB2452696B (en) | 2007-08-02 | 2009-09-23 | Cambridge Entpr Ltd | 3-(2',2'-dimethylpropanoylamino)-tetrahydropyridin-2-one and its use in pharmaceutical compositions |
| US7662967B2 (en) | 2007-08-02 | 2010-02-16 | Cambridge Enterprise Limited | Anti-inflammatory compounds and compositions |
| US8513230B2 (en) | 2010-03-05 | 2013-08-20 | Karyopharm Therapeutics, Inc. | Nuclear transport modulators and uses thereof |
| CN103402359B (zh) | 2011-01-17 | 2016-08-24 | 卡尔约药物治疗公司 | 含烯烃核运输调节剂及其用途 |
| EP2736883B1 (en) * | 2011-07-29 | 2019-09-04 | Karyopharm Therapeutics, Inc. | Nuclear transport modulators and uses thereof |
| EP2736887B1 (en) | 2011-07-29 | 2017-10-18 | Karyopharm Therapeutics, Inc. | Hydrazide containing nuclear transport modulators and uses thereof |
| IN2014DN09434A (enExample) | 2012-05-09 | 2015-07-17 | Karyopharm Therapeutics Inc | |
| WO2014144772A1 (en) | 2013-03-15 | 2014-09-18 | Karyopharm Therapeutics Inc. | Methods of promoting wound healing using crm1 inhibitors |
| CN110386919B (zh) | 2013-06-21 | 2023-07-14 | 卡尔约药物治疗公司 | 核转运调节剂及其用途 |
| CN111484483B (zh) | 2014-08-15 | 2023-05-26 | 卡尔约药物治疗公司 | 赛灵克斯的多晶型物 |
| US10526295B2 (en) | 2015-12-31 | 2020-01-07 | Karyopharm Therapeutics Inc. | Nuclear transport modulators and uses thereof |
| EP3397634A1 (en) | 2015-12-31 | 2018-11-07 | Karyopharm Therapeutics, Inc. | Nuclear transport modulators and uses thereof |
| US11602530B2 (en) | 2016-11-28 | 2023-03-14 | Biogen Ma Inc. | CRM1 inhibitors for treating epilepsy |
| CN109134510A (zh) * | 2018-11-13 | 2019-01-04 | 井冈山大学 | 制备2-氨基-5-cbz-4,5,6,7-四氢噻唑并[5,4-c]吡啶的新方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3714175A (en) * | 1970-08-14 | 1973-01-30 | Tanabe Seiyaku Co | Certain-1-aryl-3-substituted benzamido-2-pyrrolidinones |
| DE3211973A1 (de) * | 1981-04-24 | 1982-11-11 | CRC Compagnia di Ricerca Chimica S.p.A., S. Giovanni al Natisone, Udine | Verfahren zur herstellung eines pyrido-(2,3-b)-(1,4)benzodiazepins |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3545097A1 (de) * | 1985-12-19 | 1987-07-02 | Bayer Ag | 1-h-pyrido-(3,2-b)(1,4)-thiazine |
| DE3701737A1 (de) * | 1987-01-22 | 1988-08-04 | Bayer Ag | 1h-pyrido-(2,3-b)(1,4)-thiazine zur therapeutischen behandlung |
| DK196688A (da) * | 1987-04-28 | 1988-10-29 | Fujisawa Pharmaceutical Co | Bicykliske forbindelser og fremgangsmaade til fremstilling deraf |
| FI91859C (fi) * | 1987-06-17 | 1994-08-25 | Eisai Co Ltd | Analogiamenetelmä antiallergisena aineena aktiivisen bentsotiatsolijohdannaisen valmistamiseksi |
| MX13484A (es) * | 1987-10-19 | 1993-05-01 | Pfizer | Procedimiento para la obtencion de tetralinas, cromanos y compuestos relacionados, sustituidos |
| US4859776A (en) * | 1988-03-11 | 1989-08-22 | Abbott Laboratories | (S)-7-(3-aminopyrrolidin-1-yl)-1-(ortho, para-difluorophenyl)-1,4-dihydro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid and method for its preparation |
| JP3054738B2 (ja) * | 1988-07-22 | 2000-06-19 | 武田薬品工業株式会社 | チアゾロ[5,4―b]アゼピン誘導体 |
-
1991
- 1991-02-15 IL IL9724991A patent/IL97249A/en unknown
- 1991-02-19 IE IE057091A patent/IE910570A1/en unknown
- 1991-02-20 AU AU71243/91A patent/AU640449B2/en not_active Ceased
- 1991-02-20 TW TW080101248A patent/TW206970B/zh active
- 1991-02-21 NZ NZ237187A patent/NZ237187A/en unknown
- 1991-02-22 CA CA002036905A patent/CA2036905C/en not_active Expired - Fee Related
- 1991-02-22 EP EP91102566A patent/EP0443588B1/en not_active Expired - Lifetime
- 1991-02-22 AT AT91102566T patent/ATE181553T1/de not_active IP Right Cessation
- 1991-02-22 US US07/658,021 patent/US5153201A/en not_active Expired - Fee Related
- 1991-02-22 DE DE69131359T patent/DE69131359T2/de not_active Expired - Fee Related
- 1991-02-23 KR KR1019910002976A patent/KR910021406A/ko not_active Ceased
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3714175A (en) * | 1970-08-14 | 1973-01-30 | Tanabe Seiyaku Co | Certain-1-aryl-3-substituted benzamido-2-pyrrolidinones |
| DE3211973A1 (de) * | 1981-04-24 | 1982-11-11 | CRC Compagnia di Ricerca Chimica S.p.A., S. Giovanni al Natisone, Udine | Verfahren zur herstellung eines pyrido-(2,3-b)-(1,4)benzodiazepins |
Also Published As
| Publication number | Publication date |
|---|---|
| NZ237187A (en) | 1992-10-28 |
| IL97249A (en) | 1995-01-24 |
| EP0443588B1 (en) | 1999-06-23 |
| IE910570A1 (en) | 1991-08-28 |
| DE69131359T2 (de) | 1999-10-14 |
| KR910021406A (ko) | 1991-12-20 |
| TW206970B (enExample) | 1993-06-01 |
| CA2036905A1 (en) | 1991-08-24 |
| CA2036905C (en) | 2003-05-06 |
| AU7124391A (en) | 1991-08-29 |
| EP0443588A1 (en) | 1991-08-28 |
| IL97249A0 (en) | 1992-05-25 |
| US5153201A (en) | 1992-10-06 |
| ATE181553T1 (de) | 1999-07-15 |
| DE69131359D1 (de) | 1999-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2036905C (en) | Condensed thiazole compounds, their production and use | |
| DE69816608T2 (de) | 1h-pyrazolo[3,4-d]pyrimidine-4,6-dione als inhibitoren für die vermehrung von t-zellen | |
| DE69327796T2 (de) | Antiproliferative substituierte 5-thiapyrimidinon- und 5-selenopyrimidinonverbindungen | |
| AU610739B2 (en) | Thiazolo (5,4-b)azepine compounds | |
| JPH061789A (ja) | ピリジンの新規な二環式誘導体、それらの製造法、得られる新規な中間体、それらの薬剤としての使用及びそれらを含有する製薬組成物 | |
| DE10122894A1 (de) | Neue Sulfonat-substituierte Pyrazolopyridinderivate | |
| JPH07500591A (ja) | 三環性キノキサリンジオン化合物 | |
| US5482948A (en) | Pyridyl derivatives and pharmaceutical compositions comprising these compounds | |
| SK132498A3 (en) | Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase | |
| JP3111321B2 (ja) | 縮合チアゾール化合物 | |
| RU2162470C2 (ru) | 2,7-замещенные производные октагидропирроло[1,2-а]пиразина, способ лечения, фармацевтическая композиция, промежуточные соединения | |
| DE69420310T2 (de) | Substituierte Pyrrole | |
| US6294677B1 (en) | Thiopyran derivatives | |
| AU752095B2 (en) | Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha1-blocking action | |
| JPH0633276B2 (ja) | テトラヒドロチエノピリジン類 | |
| AU752510B2 (en) | Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action | |
| DE69222818T2 (de) | Kondensierte Naphthyridinderivate | |
| IL109628A (en) | 3-Carboxamido-2-pyrrolidinone and the analogous 2-peperidinone derivatives and their preparation | |
| US6211362B1 (en) | Pyrroloazepine compounds | |
| JPS62135475A (ja) | 2−置換−e−融合−〔1,2,4〕トリアゾロ−〔1,5−C〕ピリミジン | |
| US4628057A (en) | Tetrahydro-β-carboline derivatives and treatment of liver diseases | |
| DE68927538T2 (de) | Pyridinderivate und Zwischenprodukte | |
| EP0416820B1 (en) | Novel compounds exhibiting a vasodilating activity and inhibitory activity for platelet aggregation and pharmaceutical compositions containing them | |
| JPH07179467A (ja) | オキサゼピノピリドインドール誘導体及びその製造方法 |